HK1156311A1 - Preparation of pyridonecarboxylic acid antibacterials - Google Patents

Preparation of pyridonecarboxylic acid antibacterials

Info

Publication number
HK1156311A1
HK1156311A1 HK11110562.4A HK11110562A HK1156311A1 HK 1156311 A1 HK1156311 A1 HK 1156311A1 HK 11110562 A HK11110562 A HK 11110562A HK 1156311 A1 HK1156311 A1 HK 1156311A1
Authority
HK
Hong Kong
Prior art keywords
preparation
pyridonecarboxylic acid
antibacterials
acid antibacterials
pyridonecarboxylic
Prior art date
Application number
HK11110562.4A
Other languages
English (en)
Chinese (zh)
Inventor
Anthony HAIGHT
David Barnes
Geoff Zhang
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of HK1156311A1 publication Critical patent/HK1156311A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HK11110562.4A 2004-07-30 2011-10-06 Preparation of pyridonecarboxylic acid antibacterials HK1156311A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59289304P 2004-07-30 2004-07-30

Publications (1)

Publication Number Publication Date
HK1156311A1 true HK1156311A1 (en) 2012-06-08

Family

ID=35385404

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11110562.4A HK1156311A1 (en) 2004-07-30 2011-10-06 Preparation of pyridonecarboxylic acid antibacterials

Country Status (7)

Country Link
EP (4) EP2305666B1 (de)
JP (1) JP5274012B2 (de)
CA (1) CA2575148C (de)
ES (2) ES2506143T3 (de)
HK (1) HK1156311A1 (de)
MX (1) MX2007001134A (de)
WO (1) WO2006015194A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497378B2 (en) 2008-09-24 2013-07-30 Rib-X Pharmaceuticals, Inc. Process for making quinolone compounds
BRPI0921705B8 (pt) 2008-11-15 2021-05-25 Melinta Subsidiary Corp composição farmacêutica antimicrobiana e seu uso
CN103936717B (zh) * 2013-01-22 2016-08-10 上海医药工业研究院 一种delafloxacin中间体及其制备方法
CN103936718B (zh) * 2013-01-22 2016-06-29 上海医药工业研究院 一种高纯度delafloxacin的制备方法
CN103709100A (zh) * 2013-12-31 2014-04-09 南京工业大学 一种8-氯代喹诺酮衍生物的制备方法
CN104876911A (zh) * 2014-02-27 2015-09-02 南京工业大学 一种简易的方法合成德拉沙星
TWI705814B (zh) 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
EP3217974A4 (de) 2014-11-14 2018-07-25 Melinta Subsidiary Corp. Verfahren zur behandlung, prävention oder verminderung des risikos einer hautinfektion
CN106256824B (zh) * 2015-06-18 2020-10-27 重庆医药工业研究院有限责任公司 一种高纯度德拉沙星葡甲胺盐的制备方法
CN105968099B (zh) * 2016-05-12 2018-09-25 扬子江药业集团有限公司 一种德拉沙星的精制方法
CN107778293B (zh) * 2016-08-29 2023-06-16 鲁南制药集团股份有限公司 一种改进的德拉沙星的制备方法
CN108033948A (zh) * 2017-12-28 2018-05-15 北京沃邦医药科技有限公司 一种德拉沙星及其中间体的制备
CN108084161A (zh) * 2017-12-28 2018-05-29 北京沃邦医药科技有限公司 德拉沙星及其中间体的制备方法
CN110790744A (zh) * 2018-08-03 2020-02-14 南京优科生物医药研究有限公司 吡啶酮羧酸衍生物、制备方法及其组合物
CN113527262B (zh) * 2021-06-22 2022-07-15 安徽普利药业有限公司 一种德拉沙星及其葡甲胺盐的精制方法
CN114031607B (zh) * 2021-11-16 2023-01-10 海南普利制药股份有限公司 一种德拉沙星及其中间体的精制方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
EP0339406A1 (de) * 1988-04-19 1989-11-02 Hokuriku Pharmaceutical Co.,Ltd Derivate der Chinolin-3-carbonsäure, Verfahren zu ihrer Herstellung und diese Derivate enthaltende antibakterielle Zusammensetzung
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
JPH082710A (ja) 1994-06-17 1996-01-09 Ricoh Co Ltd 給紙装置
CA2290712C (en) * 1995-09-22 2003-09-09 Wakunaga Pharmaceutical Co., Ltd. Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
JPH11292873A (ja) * 1998-04-07 1999-10-26 Dainippon Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法およびその中間体
JP2001002648A (ja) * 1999-06-17 2001-01-09 Kikkoman Corp Ｎ−置換アゼパン誘導体及びそれらの塩
JP3477466B2 (ja) * 1999-09-02 2003-12-10 湧永製薬株式会社 キノリンカルボン酸誘導体又はその塩
CN1440393A (zh) * 2000-04-28 2003-09-03 田边制药株式会社 环状化合物
FR2827281B1 (fr) * 2001-07-16 2003-12-19 Sanofi Synthelabo Procede pour la preparation de la 4-methylamino-4-phenylpiperidine

Also Published As

Publication number Publication date
MX2007001134A (es) 2007-04-17
EP1789392A2 (de) 2007-05-30
CA2575148C (en) 2012-07-17
CA2575148A1 (en) 2006-02-09
EP2305666A1 (de) 2011-04-06
JP2008508309A (ja) 2008-03-21
EP2100892B1 (de) 2014-04-23
ES2506143T3 (es) 2014-10-13
JP5274012B2 (ja) 2013-08-28
EP2100892A1 (de) 2009-09-16
EP2305666B1 (de) 2014-06-25
EP2816033A1 (de) 2014-12-24
WO2006015194A3 (en) 2006-04-20
WO2006015194A2 (en) 2006-02-09
ES2482097T3 (es) 2014-08-01

Similar Documents

Publication Publication Date Title
HK1156311A1 (en) Preparation of pyridonecarboxylic acid antibacterials
IL173522A0 (en) Phenoxyacetic acid derivatives
IL181587A0 (en) Production of ??-abeta
SI1745136T1 (sl) Postopek za encimsko pripravo (S)-3-ciano-5-metilheksanojske kisline
IL183058A0 (en) Trans-fatty acid free shortening
HK1120421A1 (en) Compositions and their preparation methods for inhibiting gastric acid secretion
IL179364A0 (en) 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
HK1121955A1 (en) Lotion preparation containing pyridonecarboxylic acid derivative
EP1648416A4 (de) Pharmazeutische formulierungen zur hemmung der säuresekretion und herstellungs- und anwendungsverfahren
HK1111894A1 (en) Acid containing oxaliplatin formulations
EP1633851A4 (de) Verfahren und zusammensetzungen zur aminosäureproduktion
IL176286A0 (en) Production of dihydronepetalactone by reduction of nepetalic acid
EP1747212A4 (de) Verfahren zur herstellung von n-sulfonierten aminosäure-derivaten
EP1750767A4 (de) Pharmazeutische formulierungen zur hemmung der säuresekretion und herstellungs- und anwendungsverfahren
GB0426160D0 (en) Production of proteins
KR100496606B1 (en) Composition for anti-cancer comprising poly- -glutamic acid
EP1765761A4 (de) Neue analoga von 3-o-acetyl-11-keto-beta-boswelliasäure
IL183106A0 (en) Production of proteins
PL1751095T3 (pl) Podstawione pochodne kwasu cykloheksylokarboksylowego
SG122904A1 (en) Nucleic acid preparation
GB0428384D0 (en) Eicosapentaenoic acid
ZA200510463B (en) Methods and compositions for amino acid production
IL181417A0 (en) Chiral 3-halophthalic acid derivatives
PT1737469T (pt) Métodos e composições que empregam compostos de ácido 4-aminofenilacético
IL189465A0 (en) Preparation of thioalkylamines using chlorosulfonic acid